Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Carson PE"" wg kryterium: Autor


Tytuł :
Standardized definitions for evaluation of heart failure therapies: scientific expert panel from the Heart Failure Collaboratory and Academic Research Consortium.
Autorzy :
Abraham WT; Division of Cardiovascular Medicine, The Ohio State University, Columbus, OH, USA.
Psotka MA; Inova Heart and Vascular Institute, Falls Church, VA, USA.
Fiuzat M; Duke University Medical Center and Duke Clinical Research Institute, Durham, NC, USA.
Filippatos G; University of Cyprus Medical School, Shakolas Educational Center for Clinical Medicine, Nicosia, Cyprus.
Lindenfeld J; Heart Failure and Transplantation Section, Vanderbilt Heart and Vascular Institute, Nashville, TN, USA.
Mehran R; The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
Ambardekar AV; Division of Cardiology, University of Colorado, Aurora, CO, USA.
Carson PE; Department of Cardiology, Washington Veterans Affairs Medical Center, Washington, DC, USA.
Jacob R; Patient Representative, Dublin, OH, USA.
Januzzi JL Jr; Cardiology Division, Massachusetts General Hospital, Cardiometabolic Trials, Baim Institute for Clinical Research, Boston, MA, USA.
Konstam MA; The CardioVascular Center of Tufts Medical Center, Boston, MA, USA.
Krucoff MW; Duke University Medical Center and Duke Clinical Research Institute, Durham, NC, USA.
Lewis EF; Division of Cardiovascular Medicine, Stanford University, Palo Alto, CA, USA.
Piccini JP; Duke University Medical Center and Duke Clinical Research Institute, Durham, NC, USA.
Solomon SD; Cardiovascular Division, Brigham and Women's Hospital, Boston, MA, USA.
Stockbridge N; United States Food and Drug Administration, Silver Spring, MD, USA.
Teerlink JR; Section of Cardiology, San Francisco Veterans Affairs Medical Center and School of Medicine, University of California San Francisco, San Francisco, CA, USA.
Unger EF; Cardiovascular Division, Brigham and Women's Hospital, Boston, MA, USA.
Zeitler EP; Dartmouth-Hitchcock Medical Center and The Dartmouth Institute, Lebanon, NH, USA.
Anker SD; Division of Cardiology and Metabolism, Department of Cardiology, Berlin-Brandenburg Center for Regenerative Therapies, German Centre for Cardiovascular Research Partner Site Berlin, Charité Universitätsmedizin Berlin, Berlin, Germany.
O'Connor CM; Inova Heart and Vascular Institute, Falls Church, VA, USA.; Duke University Medical Center and Duke Clinical Research Institute, Durham, NC, USA.
Pokaż więcej
Źródło :
European journal of heart failure [Eur J Heart Fail] 2020 Dec; Vol. 22 (12), pp. 2175-2186. Date of Electronic Publication: 2020 Nov 13.
Typ publikacji :
Journal Article; Practice Guideline; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
MeSH Terms :
Heart Failure*/diagnosis
Heart Failure*/epidemiology
Heart Failure*/etiology
Heart Failure*/therapy
Terminology as Topic*
Clinical Trials as Topic/*standards
Cardiac Resynchronization Therapy ; Cardiovascular Agents/therapeutic use ; Comorbidity ; Consensus ; Defibrillators, Implantable ; Diagnostic Techniques, Cardiovascular/standards ; Electric Countershock/instrumentation ; Endpoint Determination/standards ; Europe ; Hospitalization ; Humans ; Patient Reported Outcome Measures ; Quality of Life ; Treatment Outcome ; United States
Czasopismo naukowe
Tytuł :
Covariate adjusted reanalysis of the I-Preserve trial.
Autorzy :
Ferreira JP; BHF Cardiovascular Research Centre, University of Glasgow, 126 University Place, Glasgow, G12 8TA, UK.; National Institute of Health and Medical Research (INSERM), Center for Clinical Multidisciplinary Research 1433, INSERM U1116, French Clinical Research Infrastructure Network (F-CRIN) Investigation Network Initiative-Cardiovascular and Renal Clinical Trialists (INI-CRCT), University of Lorraine, Regional University Hospital of Nancy, Nancy, France.
Dewan P; BHF Cardiovascular Research Centre, University of Glasgow, 126 University Place, Glasgow, G12 8TA, UK.
Jhund PS; BHF Cardiovascular Research Centre, University of Glasgow, 126 University Place, Glasgow, G12 8TA, UK.
Lorenzo-Almorós A; Department of Internal Medicine. Renal, Vascular and Diabetes Laboratory, Instituto de Investigaciones Sanitarias Fundación Jiménez Díaz, Universidad Autónoma de Madrid, Madrid, Spain.
Duarte K; National Institute of Health and Medical Research (INSERM), Center for Clinical Multidisciplinary Research 1433, INSERM U1116, French Clinical Research Infrastructure Network (F-CRIN) Investigation Network Initiative-Cardiovascular and Renal Clinical Trialists (INI-CRCT), University of Lorraine, Regional University Hospital of Nancy, Nancy, France.
Petrie MC; BHF Cardiovascular Research Centre, University of Glasgow, 126 University Place, Glasgow, G12 8TA, UK.
Carson PE; Cardiovascular Division, Department of Cardiology, Washington Veterans Affairs Medical Center, Washington, DC, USA.
McKelvie R; Department of Medicine, Western University, London, ON, Canada.
Komajda M; Service de Cardiologie, Hôpital Saint Joseph, Paris, France.
Zile M; Medical University of South Carolina and Ralph H. Johnson Veterans Administration Medical Center, Charleston, South Carolina, USA.
Zannad F; National Institute of Health and Medical Research (INSERM), Center for Clinical Multidisciplinary Research 1433, INSERM U1116, French Clinical Research Infrastructure Network (F-CRIN) Investigation Network Initiative-Cardiovascular and Renal Clinical Trialists (INI-CRCT), University of Lorraine, Regional University Hospital of Nancy, Nancy, France.
McMurray JJV; BHF Cardiovascular Research Centre, University of Glasgow, 126 University Place, Glasgow, G12 8TA, UK. .
Pokaż więcej
Źródło :
Clinical research in cardiology : official journal of the German Cardiac Society [Clin Res Cardiol] 2020 Nov; Vol. 109 (11), pp. 1358-1365. Date of Electronic Publication: 2020 Mar 25.
Typ publikacji :
Clinical Trial; Comparative Study; Journal Article; Multicenter Study
MeSH Terms :
Angiotensin II Type 1 Receptor Blockers/*therapeutic use
Angiotensin Receptor Antagonists/*therapeutic use
Heart Failure/*drug therapy
Stroke Volume/*physiology
Aged ; Female ; Heart Failure/physiopathology ; Hospitalization/trends ; Humans ; Male ; Middle Aged ; Prognosis
Czasopismo naukowe
Tytuł :
Safety, Performance, and Efficacy of Cardiac Contractility Modulation Delivered by the 2-Lead Optimizer Smart System: The FIX-HF-5C2 Study.
Autorzy :
Wiegn P; Department of Clinical Cardiac Electrophysiology, Dallas VA Medical Center, TX (P.W.).
Chan R; Chan Heart Rhythm Institute, Mesa, AZ (R.C.).
Jost C; Southwest Cardiovascular Associates, Mesa, AZ (C.J.).
Saville BR; Berry Consultants, Austin, TX (B.R.S.).
Parise H; Independent Consultant, Las Vegas, NV (H.P.).
Prutchi D; Impulse Dynamics, Mt. Laurel, New Jersey (D.P.).
Carson PE; Department of Medicine, Washington VA Medical Center, DC (P.E.C.).
Stagg A
Goldsmith RL; Exercise Physiology Laboratory, Columbia University Medical Center, New York (R.L.G.).
Burkhoff D; Cardiovascular Research Foundation, New York (D.B.).
Pokaż więcej
Źródło :
Circulation. Heart failure [Circ Heart Fail] 2020 Apr; Vol. 13 (4), pp. e006512. Date of Electronic Publication: 2020 Apr 08.
Typ publikacji :
Clinical Study; Comparative Study; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms :
Cardiac Pacing, Artificial*/adverse effects
Myocardial Contraction*
Pacemaker, Artificial*
Stroke Volume*
Ventricular Function, Left*
Heart Failure/*therapy
Aged ; Equipment Design ; Female ; Heart Failure/diagnosis ; Heart Failure/physiopathology ; Humans ; Male ; Middle Aged ; Prospective Studies ; Recovery of Function ; Risk Factors ; Time Factors ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Heart Failure End Points in Cardiovascular Outcome Trials of Sodium Glucose Cotransporter 2 Inhibitors in Patients With Type 2 Diabetes Mellitus: A Critical Evaluation of Clinical and Regulatory Issues.
Autorzy :
Butler J; Department of Medicine, University of Mississippi Medical Center, Jackson (J.B.).
Packer M; Baylor University Medical Center, Dallas, TX (M.P.).
Greene SJ; Duke Clinical Research Institute, Durham, NC (S.J.G., M.F., K.J.A., A.F.H.).; Division of Cardiology, Duke University School of Medicine, Durham, NC (S.J.G., A.F.H.).
Fiuzat M; Duke Clinical Research Institute, Durham, NC (S.J.G., M.F., K.J.A., A.F.H.).
Anker SD; Berlin-Brandenburg Center for Regenerative Therapies, Germany (S.D.A.).; Department of Cardiology, German Center for Cardiovascular Research partner site Berlin, Charite Universitatsmedizin Berlin (S.D.A.).
Anstrom KJ; Duke Clinical Research Institute, Durham, NC (S.J.G., M.F., K.J.A., A.F.H.).
Carson PE; Cardiovascular Division, Department of Cardiology, Washington Veterans Affairs Medical Center (P.E.C.).
Cooper LB; Inova Heart and Vascular Institute, Falls Church, VA (L.B.C., C.M.O.).
Fonarow GC; Ahmanson-UCLA Cardiomyopathy Center, University of California Los Angeles (G.C.F.).
Hernandez AF; Duke Clinical Research Institute, Durham, NC (S.J.G., M.F., K.J.A., A.F.H.).; Division of Cardiology, Duke University School of Medicine, Durham, NC (S.J.G., A.F.H.).
Januzzi JL Jr; Cardiology Division, Massachusetts General Hospital and Baim Institute for Clinical Research, Boston (J.L.J.).
Jessup M; American Heart Association, Dallas, TX (M.J.).
Kalyani RR; Division of Endocrinology, Diabetes, and Metabolism, Johns Hopkins University School of Medicine, Baltimore, MD (R.R.K.).
Kaul S; Cedars-Sinai Medical Center, Los Angeles, CA (S.K.).
Kosiborod M; Saint Luke's Mid America Heart Institute, University of Missouri-Kansas City (M.K.).; The George Institute for Global Health, University of New South Wales, Sydney, Australia (M.K.).
Lindenfeld J; Vanderbilt Heart and Vascular Institute, Nashville, TN (J.L.).
McGuire DK; Division of Cardiology, University of Texas Southwestern Medical Center, Dallas (D.K.M.).
Sabatine MS; TIMI Study Group (M.S.S.), Brigham and Women's Hospital, Boston, MA.; Division of Cardiovascular Medicine (M.S.S., S.D.S., M.V.), Brigham and Women's Hospital, Boston, MA.
Solomon SD; Division of Cardiovascular Medicine (M.S.S., S.D.S., M.V.), Brigham and Women's Hospital, Boston, MA.
Teerlink JR; Section of Cardiology, San Francisco Veterans Affairs Medical Center, CA (J.R.T.).; School of Medicine, University of California, San Francisco (J.R.T.).
Vaduganathan M; Division of Cardiovascular Medicine (M.S.S., S.D.S., M.V.), Brigham and Women's Hospital, Boston, MA.
Yancy CW; Division of Cardiology, Northwestern University Feinberg School of Medicine, Chicago, IL (C.W.Y.).
Stockbridge N; Division of Cardiovascular and Renal Products, United States Food and Drug Administration, Silver Spring, MD (N.S.).
O'Connor CM; Inova Heart and Vascular Institute, Falls Church, VA (L.B.C., C.M.O.).
Pokaż więcej
Źródło :
Circulation [Circulation] 2019 Dec 17; Vol. 140 (25), pp. 2108-2118. Date of Electronic Publication: 2019 Dec 16.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Review
MeSH Terms :
Clinical Trials as Topic/*methods
Diabetes Mellitus, Type 2/*drug therapy
Heart Failure/*drug therapy
Sodium-Glucose Transporter 2 Inhibitors/*therapeutic use
Cardiovascular Diseases/blood ; Cardiovascular Diseases/drug therapy ; Cardiovascular Diseases/epidemiology ; Diabetes Mellitus, Type 2/blood ; Diabetes Mellitus, Type 2/epidemiology ; Endpoint Determination ; Heart Failure/blood ; Heart Failure/epidemiology ; Humans ; Research Report/standards ; Sodium-Glucose Transporter 2/blood ; Sodium-Glucose Transporter 2 Inhibitors/pharmacology ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Sex-Related Differences in Heart Failure With Preserved Ejection Fraction.
Autorzy :
Dewan P; BHF Cardiovascular Research Centre, University of Glasgow, United Kingdom (P.D., R.R., R.T.C., L.S., P.S.J., M.C.P., J.J.V.M.).
Rørth R; BHF Cardiovascular Research Centre, University of Glasgow, United Kingdom (P.D., R.R., R.T.C., L.S., P.S.J., M.C.P., J.J.V.M.).; Rigshospitalet Copenhagen University Hospital, Denmark (R.R., L.K.).
Raparelli V; Center for Outcomes Research and Evaluation, Research Institute, McGill University Health Centre, Montreal, Quebec, Canada (V.R.).; Department of Experimental Medicine, Sapienza University of Rome, Italy (V.R.).
Campbell RT; BHF Cardiovascular Research Centre, University of Glasgow, United Kingdom (P.D., R.R., R.T.C., L.S., P.S.J., M.C.P., J.J.V.M.).
Shen L; BHF Cardiovascular Research Centre, University of Glasgow, United Kingdom (P.D., R.R., R.T.C., L.S., P.S.J., M.C.P., J.J.V.M.).
Jhund PS; BHF Cardiovascular Research Centre, University of Glasgow, United Kingdom (P.D., R.R., R.T.C., L.S., P.S.J., M.C.P., J.J.V.M.).
Petrie MC; BHF Cardiovascular Research Centre, University of Glasgow, United Kingdom (P.D., R.R., R.T.C., L.S., P.S.J., M.C.P., J.J.V.M.).
Anand IS; VA Medical Center, University of Minnesota, MN (I.S.A.).
Carson PE; Georgetown University, Washington DC Veterans Affairs Medical Center (P.E.C.).
Desai AS; Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA (A.S.D., M.A.P., S.D.S.).
Granger CB; Duke Clinical Research Institute, Duke University, Durham, NC (C.B.G.).
Køber L; Rigshospitalet Copenhagen University Hospital, Denmark (R.R., L.K.).
Komajda M; Department of Cardiology, Hospital Saint Joseph, France (M.K.).
McKelvie RS; St. Joseph's Healthcare Centre, Western University, London, ON, Canada (R.S.M.).
O'Meara E; Montreal Heart Institute and Université de Montreal, Quebec, Canada (E.O.).
Pfeffer MA; Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA (A.S.D., M.A.P., S.D.S.).
Pitt B; Department of Internal Medicine-Cardiology, University of Michigan School of Medicine, Ann Arbor (B.P.).
Solomon SD; Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA (A.S.D., M.A.P., S.D.S.).
Swedberg K; Department of Molecular and Clinical Medicine, University of Gothenburg, Sweden (K.S.).; National Heart and Lung Institute, Imperial College, London (K.S.).
Zile MR; Ralph H. Johnson Veterans Administration Medical Center, Medical University of South Carolina, Charleston, SC (M.R.Z.).
McMurray JJV; BHF Cardiovascular Research Centre, University of Glasgow, United Kingdom (P.D., R.R., R.T.C., L.S., P.S.J., M.C.P., J.J.V.M.).
Pokaż więcej
Źródło :
Circulation. Heart failure [Circ Heart Fail] 2019 Dec; Vol. 12 (12), pp. e006539. Date of Electronic Publication: 2019 Dec 09.
Typ publikacji :
Comparative Study; Journal Article
MeSH Terms :
Health Status Disparities*
Stroke Volume*
Ventricular Function, Left*
Heart Failure/*physiopathology
Adult ; Aged ; Cause of Death ; Comorbidity ; Death, Sudden, Cardiac/epidemiology ; Disease Progression ; Evidence-Based Medicine ; Female ; Heart Failure/diagnosis ; Heart Failure/mortality ; Heart Failure/therapy ; Hospitalization ; Humans ; Male ; Middle Aged ; Prognosis ; Quality of Life ; Randomized Controlled Trials as Topic ; Risk Assessment ; Risk Factors ; Sex Factors ; Time Factors
Czasopismo naukowe
Tytuł :
Design of a "Lean" Case Report Form for Heart Failure Therapeutic Development.
Autorzy :
Psotka MA; Inova Heart and Vascular Institute, Falls Church, Virginia. Electronic address: .
Fiuzat M; Department of Medicine, Duke University School of Medicine, Durham, North Carolina.
Carson PE; Department of Cardiology, Washington Veterans Affairs Medical Center, Washington, DC.
Kao DP; Division of Cardiology, University of Colorado School of Medicine, Aurora, Colorado.
Cerkvenik J; Medtronic Inc., Minneapolis, Minnesota.
Schaber DE; Medtronic Inc., Minneapolis, Minnesota.
Verta P; Edwards Lifesciences, Irvine, California.
Kazmierski RT; U.S. Food and Drug Administration, Silver Spring, Maryland.
Shinnar M; U.S. Food and Drug Administration, Silver Spring, Maryland.
Stockbridge N; U.S. Food and Drug Administration, Silver Spring, Maryland.
Unger EF; U.S. Food and Drug Administration, Silver Spring, Maryland.
Zuckerman B; U.S. Food and Drug Administration, Silver Spring, Maryland.
Butler J; Department of Medicine, University of Mississippi, Jackson, Mississippi.
Felker GM; Division of Cardiology, Duke University Medical Center, Durham, North Carolina.
Konstam MA; CardioVascular Center of Tufts Medical Center, Boston, Massachusetts.
Lindenfeld J; Heart Failure and Transplantation Section, Vanderbilt Heart and Vascular Institute, Nashville, Tennessee.
Solomon SD; Cardiovascular Division, Brigham and Women's Hospital, Boston, Massachusetts.
Teerlink JR; Section of Cardiology, San Francisco Veterans Affairs Medical Center and School of Medicine, University of California San Francisco, San Francisco, California.
O'Connor CM; Inova Heart and Vascular Institute, Falls Church, Virginia.
Abraham WT; Departments of Medicine, Physiology, and Cell Biology, Division of Cardiovascular Medicine, Davis Heart and Lung Research Institute, Ohio State University, Columbus, Ohio.
Pokaż więcej
Źródło :
JACC. Heart failure [JACC Heart Fail] 2019 Nov; Vol. 7 (11), pp. 913-921. Date of Electronic Publication: 2019 Aug 07.
Typ publikacji :
Journal Article
MeSH Terms :
Forms as Topic*
Medical Records*
Heart Failure/*diagnosis
Heart Failure/*therapy
Humans
Czasopismo naukowe
Tytuł :
Age-Related Characteristics and Outcomes of Patients With Heart Failure With Preserved Ejection Fraction.
Autorzy :
Tromp J; National Heart Centre Singapore and Duke-NUS Medical School, Singapore; Department of Cardiology, University of Groningen, University Medical Centre Groningen, Groningen, the Netherlands.
Shen L; BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom.
Jhund PS; BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom.
Anand IS; Department of Medicine, University of Minnesota Medical School and VA Medical Center, Minneapolis, Minnesota.
Carson PE; Department of Cardiology, Washington VA Medical Center, Washington, DC.
Desai AS; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
Granger CB; Duke Clinical Research Institute, Duke University, Durham, North Carolina.
Komajda M; Department of Cardiology, Hospital Saint Joseph, Paris, France.
McKelvie RS; Western University, London, Ontario, Canada.
Pfeffer MA; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
Solomon SD; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
Køber L; Department of Cardiology, Rigshospitalet, Copenhagen, Denmark.
Swedberg K; Department of Molecular and Clinical Medicine, Sahlgrenska Academy, University of Gothenburg and National Heart and Lung Institute, Imperial College, London, United Kingdom.
Zile MR; Medical University of South Carolina and Ralph H. Johnston Veterans Administration Medical Center, Charleston, South Carolina.
Pitt B; Department of Internal Medicine-Cardiology, University of Michigan School of Medicine, Ann Arbor, Michigan.
Lam CSP; National Heart Centre Singapore and Duke-NUS Medical School, Singapore; Department of Cardiology, University of Groningen, University Medical Centre Groningen, Groningen, the Netherlands.
McMurray JJV; BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom. Electronic address: .
Pokaż więcej
Źródło :
Journal of the American College of Cardiology [J Am Coll Cardiol] 2019 Aug 06; Vol. 74 (5), pp. 601-612.
Typ publikacji :
Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Benzimidazoles/*therapeutic use
Biphenyl Compounds/*therapeutic use
Heart Failure/*physiopathology
Irbesartan/*therapeutic use
Mineralocorticoid Receptor Antagonists/*therapeutic use
Stroke Volume/*physiology
Tetrazoles/*therapeutic use
Ventricular Function, Left/*physiology
Age Factors ; Aged ; Aged, 80 and over ; Angiotensin II Type 1 Receptor Blockers/therapeutic use ; Echocardiography ; Female ; Global Health ; Heart Failure/drug therapy ; Heart Failure/epidemiology ; Humans ; Male ; Middle Aged ; Morbidity/trends ; Prognosis ; Survival Rate/trends ; Systole
Czasopismo naukowe
Tytuł :
Insulin treatment and clinical outcomes in patients with diabetes and heart failure with preserved ejection fraction.
Autorzy :
Shen L; Department of Cardiology, The Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.; BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.
Rørth R; BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.; Rigshospitalet Copenhagen University Hospital, Copenhagen, Denmark.
Cosmi D; Department of Cardiology, Hospital of Gubbio, Gubbio, Italy.
Kristensen SL; BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.; Rigshospitalet Copenhagen University Hospital, Copenhagen, Denmark.
Petrie MC; BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.
Cosmi F; Department of Cardiology, Hospital of Cortona, Cortona, Italy.
Latini R; Department of Cardiovascular Research, IRCCS Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy.
Køber L; Rigshospitalet Copenhagen University Hospital, Copenhagen, Denmark.
Anand IS; Department of Medicine, University of Minnesota Medical School and VA Medical Center, Minneapolis, MN, USA.
Carson PE; Department of Cardiology, Washington VA Medical Center, Washington, DC, USA.
Granger CB; Duke Clinical Research Institute, Duke University, Durham, NC, USA.
Komajda M; Department of Cardiology, Hospital Saint Joseph, Paris, France.
McKelvie RS; Western University, London, Ontario, Canada.
Solomon SD; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Staszewsky L; Department of Cardiovascular Research, IRCCS Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy.
Swedberg K; Department of Molecular and Clinical Medicine, University of Gothenburg, Gothenburg, Sweden.; National Heart and Lung Institute, Imperial College London, London, UK.
Huynh T; McGill Health University Center, Division of Cardiology, Montreal, Quebec, Canada.
Zile MR; Medical University of South Carolina and Ralph H. Johnston Veterans Administration Medical Center, Charleston, SC, USA.
Jhund PS; BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.
McMurray JJV; BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.
Pokaż więcej
Źródło :
European journal of heart failure [Eur J Heart Fail] 2019 Aug; Vol. 21 (8), pp. 974-984. Date of Electronic Publication: 2019 Jul 04.
Typ publikacji :
Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms :
Diabetes Mellitus, Type 2/*drug therapy
Heart Failure/*physiopathology
Insulin/*therapeutic use
Stroke Volume/*physiology
Ventricular Function, Left/*physiology
Aged ; Cause of Death/trends ; Diabetes Mellitus, Type 2/complications ; Female ; Global Health ; Heart Failure/diagnosis ; Heart Failure/mortality ; Hospitalization/trends ; Humans ; Hypoglycemic Agents/therapeutic use ; Male ; Middle Aged ; Prognosis ; Quality of Life ; Survival Rate/trends
Czasopismo naukowe
Tytuł :
Prior Pacemaker Implantation and Clinical Outcomes in Patients With Heart Failure and Preserved Ejection Fraction.
Autorzy :
Shen L; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, Scotland, United Kingdom.
Jhund PS; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, Scotland, United Kingdom.
Docherty KF; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, Scotland, United Kingdom.
Petrie MC; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, Scotland, United Kingdom.
Anand IS; Department of Medicine, University of Minnesota Medical School, and Veterans Affairs Medical Center, Minneapolis, Minnesota.
Carson PE; Cardiovascular Division, Department of Cardiology, Washington Veterans Affairs Medical Center, Washington, DC.
Desai AS; Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
Granger CB; Division of Cardiovascular Medicine, Department of Internal Medicine, Duke Clinical Research Institute, Duke University, Durham, North Carolina.
Komajda M; Department of Cardiology, Hospital Saint Joseph, Paris, France.
McKelvie RS; Department of Medicine, Western University, London, Ontario, Canada.
Pfeffer MA; Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
Solomon SD; Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
Swedberg K; Department of Molecular and Clinical Medicine, University of Gothenburg, Sweden; National Heart and Lung Institute, Imperial College, London, United Kingdom.
Zile MR; Medical University of South Carolina, Charleston, South Carolina; Ralph H. Johnson Veterans Administration Medical Center, Charleston, South Carolina.
McMurray JJV; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, Scotland, United Kingdom. Electronic address: .
Pokaż więcej
Źródło :
JACC. Heart failure [JACC Heart Fail] 2019 May; Vol. 7 (5), pp. 418-427. Date of Electronic Publication: 2019 Apr 10.
Typ publikacji :
Journal Article
MeSH Terms :
Cardiac Pacing, Artificial/*statistics & numerical data
Heart Failure/*physiopathology
Hospitalization/*statistics & numerical data
Pacemaker, Artificial/*statistics & numerical data
Ventricular Dysfunction, Left/*physiopathology
Aged ; Aged, 80 and over ; Angiotensin II Type 1 Receptor Blockers/therapeutic use ; Benzimidazoles/therapeutic use ; Cardiovascular Diseases/mortality ; Cause of Death ; Death, Sudden, Cardiac/epidemiology ; Female ; Heart Failure/drug therapy ; Humans ; Irbesartan/therapeutic use ; Male ; Middle Aged ; Mineralocorticoid Receptor Antagonists/therapeutic use ; Mortality ; Prognosis ; Proportional Hazards Models ; Randomized Controlled Trials as Topic ; Spironolactone/therapeutic use ; Stroke Volume ; Tetrazoles/therapeutic use
Czasopismo naukowe
Tytuł :
N-Terminal Pro-B-Type Natriuretic Peptide Levels for Risk Prediction in Patients With Heart Failure and Preserved Ejection Fraction According to Atrial Fibrillation Status.
Autorzy :
Kristensen SL; BHF Cardiovascular Research Centre, University of Glasgow, United Kingdom (S.L.K., U.M.M., P.S.J., R.R., J.J.V.M.).; Department of Cardiology, Rigshospitalet University Hospital, Copenhagen, Denmark (S.L.K., U.M.M., R.R., L.K.).
Mogensen UM; BHF Cardiovascular Research Centre, University of Glasgow, United Kingdom (S.L.K., U.M.M., P.S.J., R.R., J.J.V.M.).; Department of Cardiology, Rigshospitalet University Hospital, Copenhagen, Denmark (S.L.K., U.M.M., R.R., L.K.).
Jhund PS; BHF Cardiovascular Research Centre, University of Glasgow, United Kingdom (S.L.K., U.M.M., P.S.J., R.R., J.J.V.M.).
Rørth R; BHF Cardiovascular Research Centre, University of Glasgow, United Kingdom (S.L.K., U.M.M., P.S.J., R.R., J.J.V.M.).; Department of Cardiology, Rigshospitalet University Hospital, Copenhagen, Denmark (S.L.K., U.M.M., R.R., L.K.).
Anand IS; Department of Medicine, University of Minnesota Medical School and Veterans Affairs Medical Center, Minneapolis (I.S.A.).
Carson PE; Department of Cardiology, Washington Veterans Affairs Medical Center, DC (P.E.C.).
Desai AS; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (A.S.D., M.A.P., S.D.S.).
Pitt B; Division of Cardiology, Department of Medicine, University of Michigan School of Medicine, Ann Arbor (B.P.).
Pfeffer MA; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (A.S.D., M.A.P., S.D.S.).
Solomon SD; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (A.S.D., M.A.P., S.D.S.).
Zile MR; Medical University of South Carolina and Ralph H. Johnston Veterans Affairs Medical Center, Charleston (M.R.Z.).
Køber L; Department of Cardiology, Rigshospitalet University Hospital, Copenhagen, Denmark (S.L.K., U.M.M., R.R., L.K.).
McMurray JJV; BHF Cardiovascular Research Centre, University of Glasgow, United Kingdom (S.L.K., U.M.M., P.S.J., R.R., J.J.V.M.).
Pokaż więcej
Źródło :
Circulation. Heart failure [Circ Heart Fail] 2019 Mar; Vol. 12 (3), pp. e005766.
Typ publikacji :
Journal Article; Meta-Analysis
MeSH Terms :
Atrial Fibrillation/*blood
Atrial Fibrillation/*physiopathology
Heart Failure/*blood
Heart Failure/*physiopathology
Natriuretic Peptide, Brain/*blood
Peptide Fragments/*blood
Aged ; Female ; Humans ; Male ; Middle Aged ; Prognosis ; Randomized Controlled Trials as Topic ; Risk Assessment ; Stroke Volume/physiology
Czasopismo naukowe
Tytuł :
Burden of medical co-morbidities and benefit from surgical revascularization in patients with ischaemic cardiomyopathy.
Autorzy :
Ambrosy AP; Division of Cardiology, The Permanente Medical Group, San Francisco, CA, USA.; Division of Research, Kaiser Permanente Northern California, Oakland, CA, USA.
Stevens SR; Department of Biostatistics and Bioinformatics, Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, USA.
Al-Khalidi HR; Department of Biostatistics and Bioinformatics, Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, USA.
Rouleau JL; Research Center, Montreal Heart Institute, Montreal, Quebec, Canada.
Bouabdallaoui N; Research Center, Montreal Heart Institute, Montreal, Quebec, Canada.
Carson PE; Department of Cardiology, Washington Veterans Affairs Medical Center, Washington, DC, USA.
Adlbrecht C; 4th Medical Department, Karl Landsteiner Institute for Cardiovascular and Critical Care Research, Hietzing Hospital, Vienna, Austria.
Cleland JGF; Robertson Centre for Biostatistics and Clinical Trials, University of Glasgow, Glasgow, Scotland, UK.
Dabrowski R; 2nd Department of Coronary Artery Disease, Institute of Cardiology, Warsaw, Poland.
Golba KS; Department of Electrocardiology and Heart Failure, School of Health Sciences, Medical University of Silesia, Katowice, Poland.
Pina IL; Albert Einstein College of Medicine, Montefiore Medical Center, New York, NY, USA.
Sueta CA; Division of Cardiology, University of North Carolina School of Medicine, Chapel Hill, NC, USA.
Roy A; Department of Cardiology, All India Institute of Medical Sciences, New Delhi, India.
Sopko G; Division of Cardiovascular Sciences, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA.
Bonow RO; Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Velazquez EJ; Section of Cardiovascular Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, USA.
Pokaż więcej
Corporate Authors :
STICH Trial Investigators
Źródło :
European journal of heart failure [Eur J Heart Fail] 2019 Mar; Vol. 21 (3), pp. 373-381. Date of Electronic Publication: 2019 Jan 30.
Typ publikacji :
Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural
MeSH Terms :
Cardiovascular Agents*/administration & dosage
Cardiovascular Agents*/adverse effects
Coronary Artery Bypass*/adverse effects
Coronary Artery Bypass*/methods
Coronary Artery Disease*/drug therapy
Coronary Artery Disease*/surgery
Cost of Illness*
Heart Failure*/mortality
Heart Failure*/physiopathology
Heart Failure*/psychology
Heart Failure*/therapy
Myocardial Ischemia/*complications
Cardiomyopathies/etiology ; Cardiomyopathies/therapy ; Comorbidity ; Female ; Humans ; Male ; Middle Aged ; Quality of Life ; Severity of Illness Index ; Stroke Volume ; Survival Analysis ; Walk Test/methods
Czasopismo naukowe
Tytuł :
A Randomized Controlled Trial to Evaluate the Safety and Efficacy of Cardiac Contractility Modulation.
Autorzy :
Abraham WT; Division of Cardiovascular Medicine, The Ohio State University, Columbus, Ohio. Electronic address: .
Kuck KH; Department of Cardiology, ASKLEPIOS Klinik St. Georg, Hamburg, Germany.
Goldsmith RL; Exercise Physiology Laboratory, Columbia University Medical Center, New York, New York.
Lindenfeld J; Department of Heart Failure and Transplant, Vanderbilt Heart, Nashville, Tennessee.
Reddy VY; Department of Cardiac Arrhythmia Services, The Mount Sinai Hospital, New York, New York.
Carson PE; Medical Intensive Care Unit, Washington VA Medical Center, Washington, DC.
Mann DL; Cardiovascular Division, Medicine, Washington University School of Medicine, St. Louis, Missouri.
Saville B; Berry Consultants, Austin, Texas.
Parise H; R. P. Chiacchierini Consulting, Gaithersburg, Maryland.
Chan R; Chan Heart Rhythm Institute, Mesa, Arizona.
Wiegn P; Department of Clinical Cardiac Electrophysiology, Dallas VA Medical Center, Dallas, Texas.
Hastings JL; Department of Clinical Cardiac Electrophysiology, Dallas VA Medical Center, Dallas, Texas.
Kaplan AJ; Department of Clinical Cardiac Electrophysiology, Cardiovascular Associates of Mesa, Mesa, Arizona.
Edelmann F; Department of Cardiology and Pneumology, Universität Göttingen, Göttingen, Germany.
Luthje L; Department of Cardiology and Pneumology, Universität Göttingen, Göttingen, Germany.
Kahwash R; Department of Heart Failure & Transplantation, The Ohio State University Heart and Vascular Center, Columbus, Ohio.
Tomassoni GF; Department of Clinical Cardiac Electrophysiology, Baptist Health Lexington, Lexington, Kentucky.
Gutterman DD; Cardiovascular Center, Medical College of Wisconsin, Milwaukee, Wisconsin.
Stagg A; Clinical Trials, Impulse Dynamics, Orangeburg, New York.
Burkhoff D; Cardiovascular Research Foundation, New York, New York.
Hasenfuß G; Heart Center of Göttingen, University Medical Center Göttingen, Göttingen, Germany.
Pokaż więcej
Źródło :
JACC. Heart failure [JACC Heart Fail] 2018 Oct; Vol. 6 (10), pp. 874-883. Date of Electronic Publication: 2018 May 10.
Typ publikacji :
Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Myocardial Contraction*
Electric Stimulation/*methods
Heart Failure/*therapy
Electric Stimulation/adverse effects ; Electric Stimulation/instrumentation ; Electrodes, Implanted ; Exercise Test ; Exercise Tolerance ; Female ; Heart Failure/mortality ; Heart Failure/physiopathology ; Humans ; Male ; Middle Aged ; Quality of Life ; Stroke Volume/physiology ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Trying to Make Progress on Survival in a Complicated Area: Sudden Death in HFpEF.
Autorzy :
Carson PE; Department of Cardiology, Washington Veterans Affairs Medical Center, Washington, DC. Electronic address: peter.carson@med.va.gov.
Pokaż więcej
Źródło :
JACC. Heart failure [JACC Heart Fail] 2018 Aug; Vol. 6 (8), pp. 662-664. Date of Electronic Publication: 2018 Jun 06.
Typ publikacji :
Editorial; Comment
MeSH Terms :
Heart Failure*
Death, Sudden, Cardiac ; Humans ; Stroke Volume ; Ventricular Function, Left
Opinia redakcyjna
Tytuł :
Redefining "Winning" and Its Implications in Heart Failure Clinical Trials.
Autorzy :
Carson PE; Department of Cardiology, Washington VA Medical Center, Washington, DC. Electronic address: peter.carson@med.va.gov.
Pokaż więcej
Źródło :
JACC. Heart failure [JACC Heart Fail] 2017 Aug; Vol. 5 (8), pp. 600-602.
Typ publikacji :
Editorial; Comment
MeSH Terms :
Emergency Service, Hospital*
Heart Failure*
Hospitalization ; Humans ; Physical Examination
Opinia redakcyjna
Tytuł :
Natriuretic Peptide Levels and Interaction With Treatment in HFpEF: Intriguing Findings in a "House of Cards"?
Autorzy :
Carson PE; Department of Cardiology, Washington VA Medical Center, Washington, DC. Electronic address: peter.carson@med.va.gov.
Pokaż więcej
Źródło :
JACC. Heart failure [JACC Heart Fail] 2017 Apr; Vol. 5 (4), pp. 253-255.
Typ publikacji :
Editorial; Comment
MeSH Terms :
Heart Failure*
Natriuretic Peptides*
Biomarkers ; Humans ; Natriuretic Peptide, Brain ; Stroke Volume
Opinia redakcyjna
Tytuł :
Risk of stroke in chronic heart failure patients with preserved ejection fraction, but without atrial fibrillation: analysis of the CHARM-Preserved and I-Preserve trials.
Autorzy :
Abdul-Rahim AH; BHF Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow G12 8TA, UK.
Perez AC; BHF Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow G12 8TA, UK.
MacIsaac RL; BHF Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow G12 8TA, UK.
Jhund PS; BHF Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow G12 8TA, UK.
Claggett BL; Cardiovascular Division, Brigham and Women's Hospital, Boston, MA, USA.
Carson PE; Division of Cardiology, The VeteransAffairs Medical Center, Washington, DC, USA.
Komajda M; Department of Cardiology, University Pierre and Marie Curie, Paris, France.
McKelvie RS; Population Health Research Institute, McMaster University, Hamilton, ON, Canada.
Zile MR; Division of Cardiology, Medical University of South Carolina, Charleston, SC, USA.
Swedberg K; Department of Molecular and Clinical Medicine, University of Gothenburg, Göteborg, Sweden.; National Heart and Lung Institute, Imperial College, London, UK.
Yusuf S; Population Health Research Institute, McMaster University, Hamilton, ON, Canada.; Hamilton Health Sciences, Hamilton, ON, Canada.
Pfeffer MA; Cardiovascular Division, Brigham and Women's Hospital, Boston, MA, USA.
Solomon SD; Cardiovascular Division, Brigham and Women's Hospital, Boston, MA, USA.
Lip GYH; University of Birmingham Institute of Cardiovascular Sciences, City Hospital, Birmingham, UK.
Lees KR; BHF Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow G12 8TA, UK.
McMurray JJV; BHF Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow G12 8TA, UK.
Pokaż więcej
Corporate Authors :
Candesartan in Heart failure Assessment of Reduction in Mortality and Morbidity-Preserved (CHARM-Preserved) and the Irbesartan in Heart Failure with Preserved Systolic Function (I-Preserve) Steering Committees
Źródło :
European heart journal [Eur Heart J] 2017 Mar 07; Vol. 38 (10), pp. 742-750.
Typ publikacji :
Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial
MeSH Terms :
Heart Failure/*complications
Stroke/*etiology
Adult ; Aged ; Atrial Fibrillation/mortality ; Atrial Fibrillation/physiopathology ; Double-Blind Method ; Female ; Heart Failure/mortality ; Heart Failure/physiopathology ; Humans ; Kaplan-Meier Estimate ; Male ; Middle Aged ; Risk Factors ; Stroke Volume/physiology
Czasopismo naukowe
Tytuł :
Clinical and Echocardiographic Characteristics and Cardiovascular Outcomes According to Diabetes Status in Patients With Heart Failure and Preserved Ejection Fraction: A Report From the I-Preserve Trial (Irbesartan in Heart Failure With Preserved Ejection Fraction).
Autorzy :
Kristensen SL; From BHF Cardiovascular Research Centre, University of Glasgow, Scotland, UK (S.L.K., U.M.M., P.S.J., M.C.P., J.J.V.M.); Department of Cardiology, Rigshospitalet University Hospital, Copenhagen, Denmark (S.L.K., U.M.M., L.K.); Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, UK (D.P.); Mayo Clinic, Rochester, MN (S.W.); Western University, London, ON, Canada (R.S.M.); Ralph H. Johnsons Veterans Affairs Medical Center and Medical University of South Carolina, Charleston (M.R.Z.); Division of Cardiology, University of Minnesota, Minneapolis (I.S.A.); Université Paris 6 and Hospital Pitié-Salpétrière, Paris, France (M.K.); University of Maryland Medical Center, Baltimore (J.S.G.); and Georgetown University and Washington DC Veterans Affairs Medical Center (P.E.C.).
Mogensen UM; From BHF Cardiovascular Research Centre, University of Glasgow, Scotland, UK (S.L.K., U.M.M., P.S.J., M.C.P., J.J.V.M.); Department of Cardiology, Rigshospitalet University Hospital, Copenhagen, Denmark (S.L.K., U.M.M., L.K.); Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, UK (D.P.); Mayo Clinic, Rochester, MN (S.W.); Western University, London, ON, Canada (R.S.M.); Ralph H. Johnsons Veterans Affairs Medical Center and Medical University of South Carolina, Charleston (M.R.Z.); Division of Cardiology, University of Minnesota, Minneapolis (I.S.A.); Université Paris 6 and Hospital Pitié-Salpétrière, Paris, France (M.K.); University of Maryland Medical Center, Baltimore (J.S.G.); and Georgetown University and Washington DC Veterans Affairs Medical Center (P.E.C.).
Jhund PS; From BHF Cardiovascular Research Centre, University of Glasgow, Scotland, UK (S.L.K., U.M.M., P.S.J., M.C.P., J.J.V.M.); Department of Cardiology, Rigshospitalet University Hospital, Copenhagen, Denmark (S.L.K., U.M.M., L.K.); Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, UK (D.P.); Mayo Clinic, Rochester, MN (S.W.); Western University, London, ON, Canada (R.S.M.); Ralph H. Johnsons Veterans Affairs Medical Center and Medical University of South Carolina, Charleston (M.R.Z.); Division of Cardiology, University of Minnesota, Minneapolis (I.S.A.); Université Paris 6 and Hospital Pitié-Salpétrière, Paris, France (M.K.); University of Maryland Medical Center, Baltimore (J.S.G.); and Georgetown University and Washington DC Veterans Affairs Medical Center (P.E.C.).
Petrie MC; From BHF Cardiovascular Research Centre, University of Glasgow, Scotland, UK (S.L.K., U.M.M., P.S.J., M.C.P., J.J.V.M.); Department of Cardiology, Rigshospitalet University Hospital, Copenhagen, Denmark (S.L.K., U.M.M., L.K.); Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, UK (D.P.); Mayo Clinic, Rochester, MN (S.W.); Western University, London, ON, Canada (R.S.M.); Ralph H. Johnsons Veterans Affairs Medical Center and Medical University of South Carolina, Charleston (M.R.Z.); Division of Cardiology, University of Minnesota, Minneapolis (I.S.A.); Université Paris 6 and Hospital Pitié-Salpétrière, Paris, France (M.K.); University of Maryland Medical Center, Baltimore (J.S.G.); and Georgetown University and Washington DC Veterans Affairs Medical Center (P.E.C.).
Preiss D; From BHF Cardiovascular Research Centre, University of Glasgow, Scotland, UK (S.L.K., U.M.M., P.S.J., M.C.P., J.J.V.M.); Department of Cardiology, Rigshospitalet University Hospital, Copenhagen, Denmark (S.L.K., U.M.M., L.K.); Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, UK (D.P.); Mayo Clinic, Rochester, MN (S.W.); Western University, London, ON, Canada (R.S.M.); Ralph H. Johnsons Veterans Affairs Medical Center and Medical University of South Carolina, Charleston (M.R.Z.); Division of Cardiology, University of Minnesota, Minneapolis (I.S.A.); Université Paris 6 and Hospital Pitié-Salpétrière, Paris, France (M.K.); University of Maryland Medical Center, Baltimore (J.S.G.); and Georgetown University and Washington DC Veterans Affairs Medical Center (P.E.C.).
Win S; From BHF Cardiovascular Research Centre, University of Glasgow, Scotland, UK (S.L.K., U.M.M., P.S.J., M.C.P., J.J.V.M.); Department of Cardiology, Rigshospitalet University Hospital, Copenhagen, Denmark (S.L.K., U.M.M., L.K.); Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, UK (D.P.); Mayo Clinic, Rochester, MN (S.W.); Western University, London, ON, Canada (R.S.M.); Ralph H. Johnsons Veterans Affairs Medical Center and Medical University of South Carolina, Charleston (M.R.Z.); Division of Cardiology, University of Minnesota, Minneapolis (I.S.A.); Université Paris 6 and Hospital Pitié-Salpétrière, Paris, France (M.K.); University of Maryland Medical Center, Baltimore (J.S.G.); and Georgetown University and Washington DC Veterans Affairs Medical Center (P.E.C.).
Køber L; From BHF Cardiovascular Research Centre, University of Glasgow, Scotland, UK (S.L.K., U.M.M., P.S.J., M.C.P., J.J.V.M.); Department of Cardiology, Rigshospitalet University Hospital, Copenhagen, Denmark (S.L.K., U.M.M., L.K.); Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, UK (D.P.); Mayo Clinic, Rochester, MN (S.W.); Western University, London, ON, Canada (R.S.M.); Ralph H. Johnsons Veterans Affairs Medical Center and Medical University of South Carolina, Charleston (M.R.Z.); Division of Cardiology, University of Minnesota, Minneapolis (I.S.A.); Université Paris 6 and Hospital Pitié-Salpétrière, Paris, France (M.K.); University of Maryland Medical Center, Baltimore (J.S.G.); and Georgetown University and Washington DC Veterans Affairs Medical Center (P.E.C.).
McKelvie RS; From BHF Cardiovascular Research Centre, University of Glasgow, Scotland, UK (S.L.K., U.M.M., P.S.J., M.C.P., J.J.V.M.); Department of Cardiology, Rigshospitalet University Hospital, Copenhagen, Denmark (S.L.K., U.M.M., L.K.); Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, UK (D.P.); Mayo Clinic, Rochester, MN (S.W.); Western University, London, ON, Canada (R.S.M.); Ralph H. Johnsons Veterans Affairs Medical Center and Medical University of South Carolina, Charleston (M.R.Z.); Division of Cardiology, University of Minnesota, Minneapolis (I.S.A.); Université Paris 6 and Hospital Pitié-Salpétrière, Paris, France (M.K.); University of Maryland Medical Center, Baltimore (J.S.G.); and Georgetown University and Washington DC Veterans Affairs Medical Center (P.E.C.).
Zile MR; From BHF Cardiovascular Research Centre, University of Glasgow, Scotland, UK (S.L.K., U.M.M., P.S.J., M.C.P., J.J.V.M.); Department of Cardiology, Rigshospitalet University Hospital, Copenhagen, Denmark (S.L.K., U.M.M., L.K.); Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, UK (D.P.); Mayo Clinic, Rochester, MN (S.W.); Western University, London, ON, Canada (R.S.M.); Ralph H. Johnsons Veterans Affairs Medical Center and Medical University of South Carolina, Charleston (M.R.Z.); Division of Cardiology, University of Minnesota, Minneapolis (I.S.A.); Université Paris 6 and Hospital Pitié-Salpétrière, Paris, France (M.K.); University of Maryland Medical Center, Baltimore (J.S.G.); and Georgetown University and Washington DC Veterans Affairs Medical Center (P.E.C.).
Anand IS; From BHF Cardiovascular Research Centre, University of Glasgow, Scotland, UK (S.L.K., U.M.M., P.S.J., M.C.P., J.J.V.M.); Department of Cardiology, Rigshospitalet University Hospital, Copenhagen, Denmark (S.L.K., U.M.M., L.K.); Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, UK (D.P.); Mayo Clinic, Rochester, MN (S.W.); Western University, London, ON, Canada (R.S.M.); Ralph H. Johnsons Veterans Affairs Medical Center and Medical University of South Carolina, Charleston (M.R.Z.); Division of Cardiology, University of Minnesota, Minneapolis (I.S.A.); Université Paris 6 and Hospital Pitié-Salpétrière, Paris, France (M.K.); University of Maryland Medical Center, Baltimore (J.S.G.); and Georgetown University and Washington DC Veterans Affairs Medical Center (P.E.C.).
Komajda M; From BHF Cardiovascular Research Centre, University of Glasgow, Scotland, UK (S.L.K., U.M.M., P.S.J., M.C.P., J.J.V.M.); Department of Cardiology, Rigshospitalet University Hospital, Copenhagen, Denmark (S.L.K., U.M.M., L.K.); Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, UK (D.P.); Mayo Clinic, Rochester, MN (S.W.); Western University, London, ON, Canada (R.S.M.); Ralph H. Johnsons Veterans Affairs Medical Center and Medical University of South Carolina, Charleston (M.R.Z.); Division of Cardiology, University of Minnesota, Minneapolis (I.S.A.); Université Paris 6 and Hospital Pitié-Salpétrière, Paris, France (M.K.); University of Maryland Medical Center, Baltimore (J.S.G.); and Georgetown University and Washington DC Veterans Affairs Medical Center (P.E.C.).
Gottdiener JS; From BHF Cardiovascular Research Centre, University of Glasgow, Scotland, UK (S.L.K., U.M.M., P.S.J., M.C.P., J.J.V.M.); Department of Cardiology, Rigshospitalet University Hospital, Copenhagen, Denmark (S.L.K., U.M.M., L.K.); Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, UK (D.P.); Mayo Clinic, Rochester, MN (S.W.); Western University, London, ON, Canada (R.S.M.); Ralph H. Johnsons Veterans Affairs Medical Center and Medical University of South Carolina, Charleston (M.R.Z.); Division of Cardiology, University of Minnesota, Minneapolis (I.S.A.); Université Paris 6 and Hospital Pitié-Salpétrière, Paris, France (M.K.); University of Maryland Medical Center, Baltimore (J.S.G.); and Georgetown University and Washington DC Veterans Affairs Medical Center (P.E.C.).
Carson PE; From BHF Cardiovascular Research Centre, University of Glasgow, Scotland, UK (S.L.K., U.M.M., P.S.J., M.C.P., J.J.V.M.); Department of Cardiology, Rigshospitalet University Hospital, Copenhagen, Denmark (S.L.K., U.M.M., L.K.); Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, UK (D.P.); Mayo Clinic, Rochester, MN (S.W.); Western University, London, ON, Canada (R.S.M.); Ralph H. Johnsons Veterans Affairs Medical Center and Medical University of South Carolina, Charleston (M.R.Z.); Division of Cardiology, University of Minnesota, Minneapolis (I.S.A.); Université Paris 6 and Hospital Pitié-Salpétrière, Paris, France (M.K.); University of Maryland Medical Center, Baltimore (J.S.G.); and Georgetown University and Washington DC Veterans Affairs Medical Center (P.E.C.).
McMurray JJ; From BHF Cardiovascular Research Centre, University of Glasgow, Scotland, UK (S.L.K., U.M.M., P.S.J., M.C.P., J.J.V.M.); Department of Cardiology, Rigshospitalet University Hospital, Copenhagen, Denmark (S.L.K., U.M.M., L.K.); Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, UK (D.P.); Mayo Clinic, Rochester, MN (S.W.); Western University, London, ON, Canada (R.S.M.); Ralph H. Johnsons Veterans Affairs Medical Center and Medical University of South Carolina, Charleston (M.R.Z.); Division of Cardiology, University of Minnesota, Minneapolis (I.S.A.); Université Paris 6 and Hospital Pitié-Salpétrière, Paris, France (M.K.); University of Maryland Medical Center, Baltimore (J.S.G.); and Georgetown University and Washington DC Veterans Affairs Medical Center (P.E.C.). .
Pokaż więcej
Źródło :
Circulation [Circulation] 2017 Feb 21; Vol. 135 (8), pp. 724-735. Date of Electronic Publication: 2017 Jan 04.
Typ publikacji :
Journal Article; Randomized Controlled Trial
MeSH Terms :
Echocardiography*
Biphenyl Compounds/*therapeutic use
Diabetes Mellitus, Type 2/*complications
Heart Failure/*drug therapy
Stroke Volume/*physiology
Tetrazoles/*therapeutic use
Aged ; Body Mass Index ; Cardiovascular Diseases/epidemiology ; Cardiovascular Diseases/etiology ; Diabetes Mellitus, Type 2/diagnosis ; Female ; Follow-Up Studies ; Heart Failure/diagnostic imaging ; Heart Failure/physiopathology ; Heart Ventricles/diagnostic imaging ; Heart Ventricles/physiopathology ; Hospitalization ; Humans ; Incidence ; Irbesartan ; Male ; Natriuretic Peptide, Brain/metabolism ; Peptide Fragments/metabolism ; Proportional Hazards Models ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Prognostic Value of Insulin-Like Growth Factor-Binding Protein 7 in Patients with Heart Failure and Preserved Ejection Fraction.
Autorzy :
Gandhi PU; Section of Cardiovascular Medicine, VA Connecticut, West Haven, Connecticut; Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, Connecticut.
Chow SL; Western University of Health Sciences, Pomona, California.
Rector TS; Veterans Affairs Medical Center, Minneapolis, Minnesota; University of Minnesota, Minneapolis, Minnesota.
Krum H; CCRE Therapeutics, Monash University, Melbourne, Australia.
Gaggin HK; Cardiology Division, Massachusetts General Hospital, Boston, Massachusetts.
McMurray JJ; British Heart Foundation Glasgow Cardiovascular Research Center, Glasgow, United Kingdom.
Zile MR; RHJ Department of Veterans Affairs Medical Center and Medical University of South Carolina, Charleston, South Carolina.
Komajda M; Université Paris 6; Pitie Salpetriere Hospital, Paris, France.
McKelvie RS; Population Health Research Institute and McMaster University, Hamilton, Ontario, Canada.
Carson PE; Washington VAMC and Georgetown University, Washington, DC.
Januzzi JL Jr; Cardiology Division, Massachusetts General Hospital, Boston, Massachusetts. Electronic address: .
Anand IS; Veterans Affairs Medical Center, Minneapolis, Minnesota; University of Minnesota, Minneapolis, Minnesota.
Pokaż więcej
Źródło :
Journal of cardiac failure [J Card Fail] 2017 Jan; Vol. 23 (1), pp. 20-28. Date of Electronic Publication: 2016 Jun 16.
Typ publikacji :
Journal Article; Multicenter Study; Randomized Controlled Trial
MeSH Terms :
Biphenyl Compounds/*therapeutic use
Heart Failure/*blood
Insulin-Like Growth Factor Binding Proteins/*blood
Stroke Volume/*physiology
Tetrazoles/*therapeutic use
Aged ; Angiotensin II Type 1 Receptor Blockers/therapeutic use ; Cause of Death/trends ; Female ; Follow-Up Studies ; Heart Failure/drug therapy ; Heart Failure/mortality ; Hospitalization/statistics & numerical data ; Humans ; Irbesartan ; Male ; Prognosis ; Risk Factors ; Survival Rate/trends ; Time Factors ; United States/epidemiology
Czasopismo naukowe
Tytuł :
Clinical outcomes according to QRS duration and morphology in the irbesartan in patients with heart failure and preserved systolic function (I-PRESERVE) trial.
Autorzy :
Cannon JA; Institute of Cardiovascular and Medical Sciences, BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, Scotland, UK.
Shen L; Institute of Cardiovascular and Medical Sciences, BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, Scotland, UK.
Jhund PS; Institute of Cardiovascular and Medical Sciences, BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, Scotland, UK.
Anand IS; Division of Cardiology, University of Minnesota, Minneapolis, MN, USA.
Komajda M; Université Paris 6 and Hospital Pitié-Salpétrière, Paris, France.
McKelvie RS; Hamilton Health Sciences, McMaster University, Hamilton, ON, Canada.
Zile MR; Ralph H. Johnsons Veterans Affairs Medical Center and, Medical University of South Carolina, Charleston, SC, USA.
Carson PE; Georgetown University and Washington DC Veterans Affairs Medical Center, Washington, DC, USA.
McMurray JJ; Institute of Cardiovascular and Medical Sciences, BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, Scotland, UK.
Pokaż więcej
Źródło :
European journal of heart failure [Eur J Heart Fail] 2016 Aug; Vol. 18 (8), pp. 1021-31. Date of Electronic Publication: 2016 May 15.
Typ publikacji :
Journal Article
MeSH Terms :
Angiotensin II Type 1 Receptor Blockers/*therapeutic use
Biphenyl Compounds/*therapeutic use
Bundle-Branch Block/*physiopathology
Heart Failure/*drug therapy
Tetrazoles/*therapeutic use
Aged ; Bundle-Branch Block/complications ; Cause of Death ; Female ; Heart Failure/blood ; Heart Failure/complications ; Heart Failure/physiopathology ; Hospitalization/statistics & numerical data ; Humans ; Irbesartan ; Male ; Middle Aged ; Mortality ; Natriuretic Peptide, Brain/blood ; Peptide Fragments/blood ; Prognosis ; Proportional Hazards Models ; Severity of Illness Index ; Stroke Volume ; Systole
Czasopismo naukowe
Tytuł :
A novel method to predict the proportional risk of sudden cardiac death in heart failure: Derivation of the Seattle Proportional Risk Model.
Autorzy :
Shadman R; Southern California Permanente Medical Group, Los Angeles, California. Electronic address: .
Poole JE; University of Washington, Seattle, Washington.
Dardas TF; University of Washington, Seattle, Washington.
Mozaffarian D; Harvard School of Public Health, Boston, Massachusetts; Brigham and Women's Hospital and Harvard Medical School, Boston Massachusetts.
Cleland JG; Hull York Medical School, University of Hull, Kingston-upon-Hull, United Kingdom.
Swedberg K; University of Gothenburg, Gothenburg, Sweden; Imperial College, London, United Kingdom.
Maggioni AP; Italian Association of Hospital Cardiologists, Florence, Italy.
Anand IS; Veterans Affairs Health Care System and University of Minnesota, Minneapolis, Minnesota.
Carson PE; Veterans Affairs Medical Center, Washington, DC.
Miller AB; University of Florida, Jacksonville(,) Florida.
Levy WC; University of Washington, Seattle, Washington.
Pokaż więcej
Źródło :
Heart rhythm [Heart Rhythm] 2015 Oct; Vol. 12 (10), pp. 2069-77. Date of Electronic Publication: 2015 Jun 30.
Typ publikacji :
Journal Article
MeSH Terms :
Defibrillators, Implantable*
Death, Sudden, Cardiac/*etiology
Heart Failure/*complications
Risk Assessment/*methods
Aged ; Death, Sudden, Cardiac/epidemiology ; Death, Sudden, Cardiac/prevention & control ; Female ; Follow-Up Studies ; Heart Failure/mortality ; Heart Failure/physiopathology ; Heart Failure/therapy ; Humans ; Male ; Middle Aged ; Proportional Hazards Models ; Prospective Studies ; Risk Factors ; Survival Rate/trends ; Time Factors ; Washington/epidemiology
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies